t
On 18 November 2025, conditional share awards under Craneware plc's Long Term Incentive Plan (2022) vested for three Directors and the Chief Legal Officer (PDMR). Following the surrender of shares for tax at £20.45 per share, Keith Neilson received 10,241 shares (0.029%), Craig Preston 7,612 shares (0.021%), Isabel Urquhart 5,232 shares (0.015%), and Eric Carter 7,755 shares (0.022%). Consequently, 76,953 Ordinary Shares were transferred from treasury since 22 October 2025, bringing the total number of Ordinary Shares with voting rights to 35,508,820.
| Date | 20 Nov 2025 |
| Time | 07:00:12 |
| Category | Capital structure |
| ID | 2660I |
Craneware plc
("Craneware" or the "Company")
Vesting of Long Term Incentive Plan Awards and Total Voting Rights
20 November 2025 - The Board of Craneware (AIM: CRW.L), a leader in healthcare financial performance solutions, announces that on 18 November 2025, under the terms of the Craneware plc Long Term Incentive Plan (2022) ("LTIP"), conditional awards of ordinary shares of 1p each in the Company ("Shares") which were granted to three Directors of the Company and to the Company's Chief Legal Officer, who is also a person discharging managerial responsibility ('PDMR'), vested to the extent that certain performance conditions were satisfied.
|
Director / other PDMR |
Gross number of Shares from conditional share awards vested on 18 November 2025 |
Number of shares withheld to satisfy tax liabilities on vesting of conditional share awards |
Net number of Shares received from conditional share awards vested on 18 November 2025 |
Percentage of issued share capital* of the Company |
|
|
|
|
|
|
|
Keith Neilson (CEO) |
24,269 |
(14,028) |
10,241 |
0.029% |
|
|
|
|
|
|
|
Craig Preston (CFO) |
18,039 |
(10,427) |
7,612 |
0.021% |
|
|
|
|
|
|
|
Isabel Urquhart (CPO) |
12,400 |
(7,168) |
5,232 |
0.015% |
|
|
|
|
|
|
|
Eric Carter (CLO) |
10,581 |
(2,826) |
7,755 |
0.022% |
|
|
|
|
|
|
*excluding 33,349 Ordinary Shares held in treasury.
The net amount of Shares received by three of the Directors and the Chief Legal Officer, as shown in the table above, from the vested LTIP awards was after payment of the associated tax liabilities.
No consideration was payable by each of the three Directors or by the other PDMR to receive the Shares from these LTIP awards.
The net number of Shares from these vested LTIP awards received by each of the three Directors and the other PDMR are subject to a two year post-vesting holding period.
Following this transaction, Keith Neilson holds 3,185,843 Shares which is 8.97% of the issued share capital* of the Company, Craig Preston holds 100,842 Shares which is 0.284% of the issued share capital* of the Company, Isabel Urquhart holds 18,111 Shares which is 0.051% of the issued share capital* of the Company and Eric Carter holds 28,420 Shares which is 0.080% of the issued share capital* of the Company.
Total Voting Rights
Following the vesting of these conditional share awards and also the vesting of conditional share awards for certain other employees on 18 November 2025 and the earlier exercise of share options by employees, in the period since 22 October 2025 the Company is transferring or has transferred a total of 76,953 Ordinary Shares previously held in treasury to satisfy the transactions. As a result, the Company's issued share capital now consists of 35,542,169 Ordinary Shares, of which 33,349 remain held in treasury. Accordingly, the total number of Ordinary Shares in the Company with voting rights is 35,508,820. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
PDMR notification: Keith Neilson
1. Details of the Restricted Person / person closely associated with him or her
a) Name Keith Neilson
2. Reason for the notification
a) Position / status CEO
b) Initial notification / Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Craneware plc
b) LEI 213800O2CTJ1YFXNXG05
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of
instrument Ordinary shares of 1p each in the capital of Craneware plc
b) Identification code ISIN GB00B2425G68
c) Nature of the transaction 1) Vesting of conditional share award under the Craneware plc Long Term Incentive Plan (2022)
2) Surrender of Ordinary Shares to satisfy tax liabilities on vesting of conditional share award
d) Price(s) and volume(s) 1) Volume(s) released from vested award 24,269, Price(s) £0
2) Volumes(s) surrendered 14,028, Price(s) £20.45
e) Aggregated information:
i. Aggregated volume 1) 24,269
2) 14,028
ii. Price(s) 1) £0
2) £20.45
f) Date of the transaction 2025-11-18
g) Place of the transaction Outside a trading venue
PDMR notification: Craig Preston
1. Details of the Restricted Person / person closely associated with him or her
a) Name Craig Preston
2. Reason for the notification
a) Position / status CFO
b) Initial notification / Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Craneware plc
b) LEI 213800O2CTJ1YFXNXG05
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of
instrument Ordinary shares of 1p each in the capital of Craneware plc
b) Identification code ISIN GB00B2425G68
c) Nature of the transaction 1) Vesting of conditional share award under the Craneware plc
Long Term Incentive Plan (2022)
2) Surrender of Ordinary Shares to satisfy tax liabilities on vesting of conditional share award
d) Price(s) and volume(s) 1) Volume(s) released from vested award 18,039, Price(s) £0
2) Volumes(s) surrendered 10,427, Price(s) £20.45
e) Aggregated information:
i. Aggregated volume 1) 18,039
2) 10,427
ii. Price(s) 1) £0
2) £20.45
f) Date of the transaction 2025-11-18
g) Place of the transaction Outside a trading venue
PDMR notification: Isabel Urquhart
1. Details of the Restricted Person / person closely associated with him or her
a) Name Isabel Urquhart
2. Reason for the notification
a) Position / status Chief People Officer
b) Initial notification / Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Craneware plc
b) LEI 213800O2CTJ1YFXNXG05
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of
instrument Ordinary shares of 1p each in the capital of Craneware plc
b) Identification code ISIN GB00B2425G68
c) Nature of the transaction 1) Vesting of conditional share award under the Craneware plc
Long Term Incentive Plan (2022)
2) Surrender of Ordinary Shares to satisfy tax liabilities on vesting of conditional share award
d) Price(s) and volume(s) 1) Volume(s) released from vested award 12,400, Price(s) £0
2) Volumes(s) surrendered 7,168, Price(s) £20.45
e) Aggregated information:
i. Aggregated volume 1) 12,400
2) 7,168
ii. Price(s) 1) £0
2) £20.45
f) Date of the transaction 2025-11-18
g) Place of the transaction Outside a trading venue
PDMR notification: Eric Carter
1. Details of the Restricted Person / person closely associated with him or her
a) Name Eric Carter
2. Reason for the notification
a) Position / status Chief Legal Officer
b) Initial notification / Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Craneware plc
b) LEI 213800O2CTJ1YFXNXG05
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of
instrument Ordinary shares of 1p each in the capital of Craneware plc
b) Identification code ISIN GB00B2425G68
c) Nature of the transaction 1) Vesting of conditional share award under the Craneware plc
Long Term Incentive Plan (2022)
2) Surrender of Ordinary Shares to satisfy tax liabilities on vesting of conditional share award
d) Price(s) and volume(s) 1) Volume(s) released from vested award 10,581, Price(s) £0
2) Volumes(s) surrendered 2,826, Price(s) £20.45
e) Aggregated information:
i. Aggregated volume 1) 10,581
2) 2,826
ii. Price(s) 1) £0
2) £20.45
f) Date of the transaction 2025-11-18
g) Place of the transaction Outside a trading venue
For further information, please contact:
Craneware plc +44 (0)131 550 3100
Keith Neilson, CEO
Craig Preston, CFO
Alma Strategic Communications (Financial PR) +44 (0)20 3405 0205
Caroline Forde, Kinvara Verdon, Sarah Peters [email protected]
Peel Hunt (NOMAD and Joint Broker) +44 (0)20 7418 8900
Neil Patel, Benjamin Cryer, Kate Bannatyne
Investec Bank PLC (Joint Broker) +44 (0)20 7597 5970
Patrick Robb, Virginia Bull, James Smith
Berenberg (Joint Broker) +44 (0)20 3207 7800
Mark Whitmore, Richard Andrews, Patrick Dologhan
About Craneware
For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster - that simplify the complexities of healthcare finance and operations. What sets us apart is our unique combination of deep healthcare expertise and engineering excellence, positioning us as a strategic partner rather than just a technology provider. The Craneware Group empowers healthcare organizations to achieve sustainable financial success while delivering better outcomes for the communities they serve - today and in the future. Together, we are transforming the business of healthcare.
Learn more at www.thecranewaregroup.com